Kelun-Biotech (06990) published its Monthly Return for Equity Issuer for November 2025. The document indicates that the total authorized share capital remains at RMB 233,185,969, with no changes in the distribution of H shares, domestic shares, or unlisted foreign shares compared with the previous month.
The number of issued H shares stands at 162,769,979, while domestic shares remain at 65,773,800 and unlisted foreign shares total 4,642,190. Treasury shares are reported at zero. No share options, warrants, or convertible securities are noted in the announcement, reflecting no additional share movements or cancellations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments